UNSPSC 51413601: Cinepazet

This classification denotes a vasodilating agent with the molecular formula C20H28N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0LC95WWE9Q, chemically known as 4-(1- oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-1-piperazineacetic acid, ethyl ester but generally known as cinepazet, which bears US NIH Compound Identifier 6436156. European Medicines Agency schedules Cinepazet in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06291MIG. The term CINEPAZET is an International Non-Proprietary Name.

UNSPSC 51413601 Cinepazet is a Commodity-tier code that does not reflect the work actually being solicited under it in recent state and local procurement. The single recent opportunity on record—the City of Tampa Fire Rescue's April 2026 bid for Advanced Life Support Medications (Labetalol, Epinephrine, Adenosine, and Diltiazem)—is a pharmaceutical procurement for emergency medical services use, not cinepazole or any related compound. The code appears to be misclassified in the source data. State and local procurement activity under this code shows no recent relevant opportunities; the Tampa solicitation represents a misalignment between the UNSPSC category name and the goods actually being procured.

Without additional recent opportunities correctly tagged to this code, geographic spread and issuing-body patterns cannot be characterized. Procurement professionals evaluating this code should verify whether the UNSPSC 51413601 classification is accurate in their sourcing systems or whether Tampa's Advanced Life Support Medications solicitation should have been coded to a pharmaceutical or emergency medical supply category instead.